ImageneBio, Inc. Common Stock

IMANASDAQ • USD
3.97 USD
↗ 0.77 (24.00%)🟢LIVE (AS OF 02:25 PM EST)
🟢Market: OPEN

Shares of ImageneBio, Inc. Common Stock (IMA) are trading at $3.97. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, IMA appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 16, 2026.

Open?$3.20
High?$3.97
Low?$3.12
Prev. Close?$3.20
Volume?61.6K
Avg. Volume?12.8K
VWAP?$3.48
Rel. Volume?4.82x
Bid / Ask
Bid?$3.31 × 100
Ask?$4.56 × 100
Spread?$1.25
Midpoint?$3.93
Valuation & Ratios
Market Cap?39.9M
Shares Out?12.5M
Float?8.5M
Float %?75.2%
P/E Ratio?N/A
P/B Ratio?0.31
EPS?-$3.48
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
Employees
18
Market Cap
39.9M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2025-07-28
Address
12526 HIGH BLUFF DRIVE
SAN DIEGO, CA 92130
Phone: 857-343-8292
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
1
Momentum?
77
Short Sent.?
68
Piotroski F-Score?0/9Weak
Altman Z-Score?-1.08Distress
Confidence?38%Very Low
Full Fundamental Analysis →
Short InterestModerate
Short % of Float?0.54%Low
Short Interest?46.0K
Days to Cover?4.0
Free Float8.5M
Avg Daily Volume11.6K
Settlement Date2026-10-30
Financial Health
Current Ratio?16.17Strong
Quick Ratio?16.17Strong
Cash Ratio?10.51Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.31CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.9CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
5
-33.8%WEAK▾
ROA?
S&P
3
-30.4%WEAK▾
Cash Flow & Enterprise
FCF?$-40612000
Enterprise Value?$-44992901
Fundamentals ratios updated end of day